跳至主要内容
临床试验/EUCTR2016-001213-24-NL
EUCTR2016-001213-24-NL进行中(未招募)1 期

Infection prevention and immune modulation by bacterial lysates: gaining insight into the mechanism of an old therapy in patients with asthma

Franciscus Gasthuis0 个研究点开始时间: 2016年4月25日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with proven asthma (airway responsiveness proven by reversibility and histamine PC20 < 8 mg/ml)) who have recurrent airway signs and symptoms despite optimal maintenance medication (medium/high dose inhalation corticosteroid and long-acting ß2-agonist; GINA 4).
  • Specific inclusion criteria
  • -= 2 documented asthma exacerbations in the past winter season (see definition below)
  • -and Asthma Control Questionnaire (ACQ) > 1.5 despite maintenance medication
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 30
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 90
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Other relevant respiratory conditions, e.g. OSAS, bronchiectasis
  • -Systemic immunological diseases
  • -Current smoking or past smoking > 10 pack years
  • -Other untreated co-morbidity, such as gastro-esophageal reflux disease, ENT problems, psychological disorders
  • -Non-compliance to current medication or inhalation technique
  • -Communication difficulties
  • -Pregnancy or planned pregnancy within 2 years

研究者

发起方
Franciscus Gasthuis

相似试验